Iovance Biotherapeutics Inc (IOVA)

07:09 AM

Iovance Biotherapeutics: Only For The Brave (NASDAQ:IOVA) - Seeking Alpha

07:09 AM

Apr 21, 2025

Commit To Buy Iovance Biotherapeutics At $2.50, Earn 35.1% Annualized Using Options - Nasdaq

Apr 21, 2025

Apr 20, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 20, 2025

Apr 19, 2025

Iovance Biotherapeutics (IOVA) Projects Strong Growth with FDA-Approved Therapy - GuruFocus

Apr 19, 2025

Apr 19, 2025

This Biotech Stock Could Be the Best Investment of the Decade - The Globe and Mail

Apr 19, 2025

Apr 18, 2025

Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts? - Insider Monkey

Apr 18, 2025

Apr 18, 2025

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | IOVA Stock News - GuruFocus

Apr 18, 2025

Apr 18, 2025

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Apr 18, 2025

Apr 18, 2025

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire Inc.

Apr 18, 2025

Apr 17, 2025

11 Most Promising Penny Stocks According to Analysts - Insider Monkey

Apr 17, 2025

Apr 16, 2025

Is Iovance Biotherapeutics Inc. (NASDAQ:IOVA) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Yahoo Finance

Apr 16, 2025

Apr 15, 2025

13 Best Biotech Penny Stocks to Buy According to Hedge Funds - Insider Monkey

Apr 15, 2025

Apr 14, 2025

Barclays Adjusts Iovance Biotherapeutics (IOVA) Price Target Ami - GuruFocus

Apr 14, 2025

Apr 14, 2025

Is Iovance Biotherapeutics a Millionaire-Maker? - MSN

Apr 14, 2025

Apr 14, 2025

Barclays cuts Iovance Biotherapeutics target to $5, keeps rating By Investing.com - Investing.com Canada

Apr 14, 2025

Apr 13, 2025

Iovance Biotherapeutics (IOVA) Eyes Revenue Growth with TIL Ther - GuruFocus

Apr 13, 2025

Apr 10, 2025

TILs’ Tomorrow Bringing More Cancers Under Immune Control - Genetic Engineering and Biotechnology News

Apr 10, 2025

Apr 09, 2025

Iovance Biotherapeutics, Inc. (IOVA): Among Stocks Under $10 that Will Triple - Insider Monkey

Apr 09, 2025

Apr 08, 2025

10 Stocks Under $10 that Will Triple - Insider Monkey

Apr 08, 2025

Apr 07, 2025

Trading (IOVA) With Integrated Risk Controls - news.stocktradersdaily.com

Apr 07, 2025

Apr 04, 2025

Iovance Biotherapeutics, Inc. (IOVA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Apr 04, 2025

Apr 04, 2025

Iovance Biotherapeutics (NasdaqGM:IOVA) Drops 10% Over The Week In Market Correction - Yahoo Finance

Apr 04, 2025

Apr 03, 2025

Osteosarcoma Market Set for Groundbreaking Expansion by 2032, Forecasts DelveInsight | Aurora Biopharma, BioAtla, Iovance Biotherapeutics, Isofol Medical AB, Bristol-Myers Squibb, Cellestia Biotech - The Globe and Mail

Apr 03, 2025

Apr 03, 2025

Iovance: Less And Less Likely To Reap Reward From Its Pioneering Work (NASDAQ:IOVA) - Seeking Alpha

Apr 03, 2025

Apr 01, 2025

Institutional Investors May Adopt Severe Steps After Iovance Biotherapeutics, Inc.'s (NASDAQ:IOVA) Latest 8.3% Drop Adds to a Year Losses - 富途牛牛

Apr 01, 2025

Apr 01, 2025

Tumor-Infiltrating Lymphocytes Treatment Market Size in 7MM - openPR.com

Apr 01, 2025

Apr 01, 2025

Uveal Neoplasms Treatment Market Size in 7MM is expected to grow - openPR.com

Apr 01, 2025

Mar 27, 2025

Cell Therapy Veteran With 16 Successful Launches Joins TScan Leadership - Stock Titan

Mar 27, 2025

Mar 27, 2025

TScan Therapeutics Appoints Commercial Leader Stephen Camiolo as Senior Vice President, Market Access - GlobeNewswire

Mar 27, 2025

Mar 26, 2025

Top 3 Health Care Stocks That Are Set To Fly This Month - Benzinga

Mar 26, 2025

Mar 25, 2025

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) The Top Penny Stock That Will Skyrocket? - Insider Monkey

Mar 25, 2025

Mar 22, 2025

1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street - AOL.com

Mar 22, 2025

Mar 21, 2025

Iovance Biotherapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4) - MarketScreener

Mar 21, 2025

Mar 21, 2025

Iovance Expands Team: 308,710 Stock Options Awarded as Growth Accelerates - StockTitan

Mar 21, 2025

Mar 18, 2025

Iovance: The Company Makes It Hard To Estimate Revenue Growth (NASDAQ:IOVA) - Seeking Alpha

Mar 18, 2025

Mar 18, 2025

Philly weekly roundup: Iovance Biotherapeutics expands; Jawnt-SpotHero partnership; Mayor's budget address - Technical.ly

Mar 18, 2025

Mar 17, 2025

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) the Most Oversold Penny Stocks to Buy According to Analysts? - Insider Monkey

Mar 17, 2025

Mar 17, 2025

Stifel maintains Buy on Iovance Biotherapeutics stock, $18 target By Investing.com - Investing.com Canada

Mar 17, 2025

Mar 15, 2025

10 Most Oversold Penny Stocks to Buy According to Analysts - Insider Monkey

Mar 15, 2025

Mar 13, 2025

Iovance at Barclays Conference: Strategic Growth and Expansion - Investing.com

Mar 13, 2025

Mar 12, 2025

Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up? - MSN

Mar 12, 2025

Mar 12, 2025

Melanoma Therapeutics Market to Reach $ 8.35 Bn by 2032Key - openPR

Mar 12, 2025

Mar 12, 2025

Proficio Capital Partners LLC Acquires New Stake in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World

Mar 12, 2025

Mar 12, 2025

SBI Securities Co. Ltd. Acquires New Stake in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World

Mar 12, 2025

Mar 10, 2025

Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today - AOL

Mar 10, 2025

Mar 09, 2025

Can Amtagvi Drive IOVA's Return To Glory - RTTNews

Mar 09, 2025

Mar 07, 2025

IOVA stock touches 52-week low at $3.62 amid market challenges - Investing.com

Mar 07, 2025

Mar 07, 2025

Iovance Biotherapeutics Inc to Host Earnings Call - ACCESS Newswire

Mar 07, 2025